These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 3375805)

  • 1. Risk assessment reappraisals.
    Science; 1988 May; 240(4856):1125-6. PubMed ID: 3375805
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk assessment. End of an era.
    Anderson C
    Nature; 1991 Sep; 353(6342):289. PubMed ID: 1922329
    [No Abstract]   [Full Text] [Related]  

  • 3. [The risk assessment of cancer morbidity in the joint action of carcinogens].
    Shaĭkina OI; Shaĭkin AB; Kon'shina LG
    Gig Sanit; 1999; (1):41-3. PubMed ID: 10199078
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinogenic effects of benzene--a status update and research needs to improve risk assessments: US EPA perspective. Environmental Protection Agency.
    Sonawane B; Bayliss D; Valcovic L; Chen C; Rodan B; Farland W
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):471-2. PubMed ID: 11086954
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinogens and human health: Part 3.
    Cogliano VJ; Farland WH; Preuss PW; Wiltse JA; Rhomberg LR; Chen CW; Mass MJ; Nosnow S; White PD; Parker JC
    Science; 1991 Feb; 251(4994):606-8. PubMed ID: 1992511
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory science. A commentary.
    Shindell S
    J Occup Med; 1988 Jul; 30(7):568-9. PubMed ID: 3397784
    [No Abstract]   [Full Text] [Related]  

  • 7. US broadens scientific base of controls on carcinogens.
    Reichhardt T
    Nature; 1996 Apr; 380(6576):659. PubMed ID: 8614448
    [No Abstract]   [Full Text] [Related]  

  • 8. Default assumptions in carcinogen risk assessment used by regulatory agencies.
    Moolenaar RJ
    Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 2):S135-41. PubMed ID: 7724845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental health. Second look at arsenic finds higher risk.
    Kaiser J
    Science; 2001 Sep; 293(5538):2189. PubMed ID: 11567118
    [No Abstract]   [Full Text] [Related]  

  • 10. Living with and reforming the Delaney Clause.
    Degnan FH; Flamm WG
    Food Drug Law J; 1995; 50(2):235-56. PubMed ID: 10342993
    [No Abstract]   [Full Text] [Related]  

  • 11. [A causal connection between lung cancer and passive smoking: the report from the American Environmental Protection Agency].
    Jansen DF; van Barneveld TA; van Leeuwen FE
    Ned Tijdschr Geneeskd; 1994 Mar; 138(10):500-3. PubMed ID: 8139707
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer risk assessment: evolution of the process.
    Farland WH
    Prev Med; 1996; 25(1):24-5. PubMed ID: 8778755
    [No Abstract]   [Full Text] [Related]  

  • 13. The perils and promise of modern risk assessment: the example of trichloroethylene.
    Kester JE; Clewell HJ
    Clin Occup Environ Med; 2004 Aug; 4(3):497-512, vi-vii. PubMed ID: 15325318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of in vivo mutation data can inform cancer risk assessment.
    Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential new approaches for children's inhalation risk assessment.
    Firestone M; Sonawane B; Barone S; Salmon AG; Brown JP; Hattis D; Woodruff T
    J Toxicol Environ Health A; 2008; 71(3):208-17. PubMed ID: 18097946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPA rebuffs challenge to its assessment of dioxin data.
    Reichardt T
    Nature; 1994 Sep; 371(6495):272. PubMed ID: 8090187
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk assessment: the default conservatism controversy.
    Barnard RC
    Regul Toxicol Pharmacol; 1995 Jun; 21(3):431-8. PubMed ID: 7480897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: R. Peto et al., Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res., 51: 6415-6451, 1991, and K. S. Crump et al., Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res., 36: 2973-2979, 1976.
    Stöhrer G
    Cancer Res; 1993 Sep; 53(17):4107-8. PubMed ID: 8257518
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of 'secondary mechanism' in the regulation of carcinogens; a chronology.
    Scheuplein RJ
    Cancer Lett; 1995 Jun; 93(1):103-12. PubMed ID: 7600537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alar's risks.
    Kimm VJ
    Science; 1991 Nov; 254(5036):1276. PubMed ID: 1962184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.